Finasteride 5mg 100 tablets/bottle Core Description *
Pharmaceutical -Grade Preparations | 5α-Reductase Inhibitor
Chemical name : N-(1,1-dimethylethyl)-3-oxo-4-aza-5α-androst-1-ene-17β-amide
CAS number : 98319-26-7
Molecular formula : C₂₃H₃₆N₂O₂
Molecular weight : 372.55
Specifications : 5mg/tablet, 100 tablets/bottle
Dosage form : Film-coated tablets
Appearance : Light blue or white tablets with a dividing line
Core Effects
Finasteride is a specific 5α-reductase inhibitor . Due to its high efficacy in inhibiting dihydrotestosterone (DHT) production , it is widely used in the treatment of male androgenic alopecia and the management of benign prostatic hyperplasia .
✅ Precisely inhibit DHT conversion :
Inhibits type II 5α-reductase , reducing serum DHT levels by more than 70%
Reduce DHT attack on hair follicles and delay hair loss from the root
✅ Prostate protection effect :
Reduce prostate size and improve symptoms of benign prostatic hyperplasia
Reduce the risk of acute urinary retention and the need for surgery
✅ High security features :
Does not affect testosterone levels and maintains normal sexual function
Selective inhibition with lower risk of side effects
✅ Advantages :
Take orally once a day , high medication compliance
Long-term effects are stable and significant with continued use
End Product Preparation Guide
1. Tablet preparation (5 mg/tablet) :
Example recipe (for 1000 tablets):
Finasteride raw material: 5.0g
Microcrystalline cellulose: 80.0g
Lactose: 50.0g
Cross-linked carboxymethyl cellulose sodium: 8.0g
Magnesium stearate: 2.0g
Preparation process :
Raw material pretreatment : micronization (D90≤10μm)
Equal amount incremental mixing : gradually mix with diluent
Wet granulation : granulate with appropriate amount of purified water and dry in fluid bed at 50°C
Granulation : 20 mesh sieve granules, add flow aids and lubricants
Tableting : 8mm round die, 8-10kN pressure tableting
Film coating : Gastro-soluble film coating to improve stability and palatability
Quality Control :
Content uniformity : RSD≤3% (UV-HPLC detection)
Dissolution rate : ≥85% in 30 minutes (paddle method, 50 rpm)
Related substances : Single impurity ≤ 0.5%, total impurities ≤ 1.0%
2. Preparation Notes :
Anti- cross contamination : Dedicated production line to avoid cross contamination with other drugs
Female operation protection : Pregnant women are prohibited from using this product, and strict protection is required during the production process
Packaging requirements : Aluminum foil blister packaging, moisture-proof and light-proof
Usage Protocol
1. Male hair loss treatment :
Standard dose : 1 mg/day (1 tablet divided into 5 portions)
Taking time : fixed time every day, before or after meals
Time to see results :
3-6 months: Hair loss decreases
6-12 months: New hair is obvious
Long-term use: The effect is maintained continuously
2. Treatment of benign prostatic hyperplasia (BPH) :
Therapeutic dose : 5 mg/day (1 tablet/day)
Symptom improvement :
3-6 months: Improved urine flow rate
6-12 months: Prostate volume shrinks
Maintenance therapy : Long-term use to prevent progression
3. Dose fractionation method :
Precise splitting : Use a tablet splitter to split the pills evenly
Storage method : After splitting, keep the tablets sealed and away from light.
Dose adjustment : Individualized adjustment based on efficacy and tolerability
4. Use in special populations :
Elderly : No dosage adjustment is required; monitor PSA carefully.
Hepatic and renal insufficiency : Mild to moderate, no adjustment required; use with caution in severe cases
Women : Contraindicated for pregnant women and women of childbearing age
Why choose finasteride ?
Precise targeted treatment to inhibit DHT production from the root
Dual treatment advantages , suitable for both hair loss and benign prostatic hyperplasia
Excellent long-term safety , 20 years of clinical experience
Quality Assurance :
GMP compliant production , content uniformity testing for each batch
Stability test : Accelerated test for 6 months meets the standard
Third-party laboratory report (COA) is included with the product
Professional Packaging :
Moisture-proof bottle : 100 tablets/bottle, built-in desiccant
Light- proof : Brown glass bottle or aluminum-plastic blister
Child safety cap : prevent children from accidentally swallowing
Conclusion
Finasteride tablets are a standard treatment option for male androgenic alopecia and benign prostatic hyperplasia (BPH) . They are particularly suitable for early intervention of hair loss and management of prostate symptoms . The recommended dose is 1mg/day (for hair loss) or 5mg/day (for BPH) .
Need anything, please contact us
|
|
+852 4671 8216 |
|
Telegram |
Allenraws |
|
|
Allenraws810@gmail.com |

Hot Tags: stromusc finasteride 5mg*100/bottle oral tablets, China stromusc finasteride 5mg*100/bottle oral tablets manufacturers, suppliers, factory, Steroid Cycle Support, Methyltestosterone to use, Increases phosphocreatine stores, dromostanolone propionate, Letrozole Elevates Natural Testosterone By 30 50 , steroid finished tablets

